Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
Stephanie A FisherJingtong HuangAshley Y DuBordNicole Y XuMolly BeestrumCharlotte NiznikAndrea M YeungKevin T NguyenDavid C KlonoffLynn M YeePublished in: Journal of diabetes science and technology (2023)
Use of CSII (vs MDI) for pregestational DM in pregnancy is associated with higher odds of cesarean delivery and delivery of an LGA neonate. Further evaluation of how CSII use may influence neonatal size and delivery route is warranted.